FDA approves Biogen’s long-acting MS drug
August 18, 2014Sales and Marketing Avonex, Biogen, FDA, MS, Rebif, plegridy, tecfidera
Biogen Idec has racked up another approval over the weekend after its latest multiple sclerosis treatment Plegridy gained FDA backing. …
The end of salesmanship?
August 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Rose, a bpi, all trials, evidence, gold acre, sales, salesmanship
Although my specialism for the last 35 years has been clinical research, I actually started in the pharmaceutical industry as …
Oxford BioMedica takes on executive position
August 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioMedica, blake
Gene and cell therapy firm Oxford BioMedica has confirmed that non-executive director Dr Paul Blake has been appointed to the …
Charities ‘disappointed’ in NICE and Janssen
August 15, 2014Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, prostate
The Institute of Cancer Research and Prostate Cancer UK are both urging NICE and Janssen to ‘get their act together’ …
Life hires principal writer from PAN
August 15, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Catriona Hampton, Life, Pan
Catriona Hampton has joined Life Healthcare Communications in Windsor, UK as a principal writer. Hampton who graduated in Immunology at …
SHL to exhibit at the 2014 PDA Conference in California, USA
August 15, 2014Sales and Marketing auto injector, pda 2014, shl event, shl pda 2014
The growth of the auto injector industry has been driven largely in part by the need to improve patient compliance …
InterMune stock jumps on suitor claims
August 14, 2014Sales and Marketing Boehringer, Esbriet, FDA, GSK, IPF, InterMune
Riding high of the success of its new lung drug Esbriet, InterMune has become the focus of some serious takeover …
Vertex ditches its once-stellar hep C drug
August 14, 2014Sales and Marketing Gilead, Incivek, Vertex, hep C, sovaldi
Vertex will stop selling its once-blockbuster hepatitis C drug in the US this autumn after being crushed by new therapies. …
Amgen cancer drug fails key test
August 14, 2014Sales and Marketing Amgen, Cancer, Kyprolis, myeloma
Amgen’s new rare cancer drug has failed in a late-stage trial just a year after the US biotech spent $10.4 …
New chief executive for Medivir
August 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medivir, Niklas Prager
Niklas Prager has been named as the new president and chief executive of Sweden-based pharma firm Medivir. Starting in September, …
Pharma publisher confirms two hires
August 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Samedan, george underwood, pharmafile. pharmafocus, tom robinson
Samedan Pharmaceutical Publishers has appointed two editorial and production assistants to join Pharmafile and Pharmafocus. Tom Robinson (pictured right) joins Pharmafile …
NHS in Scotland deploys mobile healthcare
August 13, 2014Medical Communications, Sales and Marketing NHS, Safe Patient Systems, Scotland, digital, nhs scotland, tablets
Mobile healthcare firm Safe Patient Systems is partnering with NHS Greater Glasgow and Clyde (NHSGGC) to provide mobile healthcare services …
Pfizer teams up with Google-backed 23andMe
August 13, 2014Research and Development, Sales and Marketing 23andME, Crohn’s disease, Pfizer, google, ulcerative colitis
Pfizer and genetics testing firm 23andMe have come together in a research pact aimed at finding the genetic cause of …
Sanofi signs $925 million inhaled insulin deal
August 13, 2014Sales and Marketing Afrezza, French, Sanofi, diabetes, fad, insulin
Sanofi could pay out as much as $925 million for global rights to the world’s only approved inhaled insulin just …
Cancer Research UK appeals for clarity on Wikipedia
August 13, 2014Medical Communications, Sales and Marketing Cancer, Cancer Research UK, wikimania, wikipedia
Cancer Research UK is calling upon the medical community to become more involved with Wikipedia to ensure better accuracy of …
Untested Ebola drugs can be used in Africa
August 13, 2014Research and Development, Sales and Marketing Africa, Biocryst Pharmaceuticals, Ebola, Siga Technologies, Tekmira Pharmaceuticals, WHO, world health organization, zmapp
The World Health Organization will allow untested treatments for Ebola to be used in West Africa as the death toll …
Cost of diabetes treatment soars in England
August 13, 2014Medical Communications, Research and Development, Sales and Marketing Lantus, NHS, Sanofi, diabetes
The NHS spent more than £2.2 million on average every day over the last financial year on diabetes medicines, according …
GSK now faces bribery allegations in Syria
August 13, 2014Medical Communications, Sales and Marketing China, GSK, bribery
GlaxoSmithKline faces fresh allegations that it bribed Syrian doctors and officials to boost sales of its medicines in what is …
Spectrum appoints two medical writers
August 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dominique Helburg, Nuša Farič, Spectrum
UK Healthcare consultancy firm Spectrum Regulatory Solutions has appointed two new medical writers to further expand its team. Prior to …
Nicox makes changes to board
August 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adrienne Graves, Luzi von Bidder, NicOx
French ophthalmic firm Nicox has confirmed that Dr Adrienne Graves and Luzi von Bidder will be joining its board of …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
